Archives

img-01

Will China Relax Tough Drug Prices

Everyone knows that the China drug market is very large. However, national and provincial tenders, Volume Based Procurement (VBP), the DRG system and other recent measures have significantly lowered pricing and reimbursements. To get drug reimbursement in China, a company needs to... Read More

img-01

CDx Development Slow in China

While the West and Japan are prioritizing personalized medicine and the use of Companion Diagnostics (CDx) to determine which patients will benefit from specific drugs, development in China has been slow. In China, CDx products are classified and regulated by existing medical... Read More